Loading...
Sartorius Stedim Biotech S.A.
DIM.PA•EURONEXT
HealthcareMedical - Instruments & Supplies
€193.65
€-0.20(-0.10%)
Sartorius Stedim Biotech S.A. (DIM.PA) Financial Performance & Statements
Review Sartorius Stedim Biotech S.A.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.16%
↑ 0.16%
Operating Income Growth
-23.51%
↓ 23.51%
Net Income Growth
-43.46%
↓ 43.46%
Operating Cash Flow Growth
29.44%
↑ 29.44%
Operating Margin
15.61%
↑ 15.61%
Gross Margin
43.89%
↑ 43.89%
Net Profit Margin
7.15%
↑ 7.15%
ROE
5.19%
↑ 5.19%
ROIC
6.08%
↑ 6.08%
Sartorius Stedim Biotech S.A. (DIM.PA) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Sartorius Stedim Biotech S.A. stock.
| Metric | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 |
|---|---|---|---|---|
| Revenue | $751.30M | $655.40M | $706.40M | $666.90M |
| Cost of Revenue | $435.00M | $380.00M | $400.10M | $358.50M |
| Gross Profit | $316.30M | $275.40M | $306.30M | $308.40M |
| Gross Profit Ratio | $0.42 | $0.42 | $0.43 | $0.46 |
| R&D Expenses | $37.10M | $37.30M | $35.20M | $34.50M |
| SG&A Expenses | $174.00M | $155.70M | $158.30M | $160.70M |
| Operating Expenses | $206.70M | $193.00M | $193.50M | $195.20M |
| Total Costs & Expenses | $641.70M | $573.00M | $593.60M | $553.70M |
| Interest Income | -$21.40M | $2.60M | $12.80M | $33.10M |
| Interest Expense | $11.20M | $37.90M | $51.70M | $0.00 |
| Depreciation & Amortization | $80.60M | $76.20M | $74.50M | $70.40M |
| EBITDA | $132.70M | $149.60M | $191.70M | $196.00M |
| EBITDA Ratio | $0.18 | $0.23 | $0.27 | $0.29 |
| Operating Income | $109.60M | $82.40M | $112.80M | $113.20M |
| Operating Income Ratio | $0.15 | $0.13 | $0.16 | $0.17 |
| Other Income/Expenses (Net) | -$68.70M | -$46.90M | -$38.90M | -$36.20M |
| Income Before Tax | $40.90M | $35.50M | $65.40M | $77.00M |
| Income Before Tax Ratio | $0.05 | $0.05 | $0.09 | $0.12 |
| Income Tax Expense | -$5.40M | $9.20M | $16.80M | $20.00M |
| Net Income | $45.60M | $25.50M | $47.60M | $56.00M |
| Net Income Ratio | $0.06 | $0.04 | $0.07 | $0.08 |
| EPS | $0.47 | $0.26 | $0.49 | $0.58 |
| Diluted EPS | $0.47 | $0.26 | $0.49 | $0.58 |
| Weighted Avg Shares Outstanding | $96.78M | $98.08M | $97.32M | $96.72M |
| Weighted Avg Shares Outstanding (Diluted) | $96.78M | $98.08M | $97.32M | $96.72M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan